Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes

Thrombosis and Haemostasis

Volumn 103, Issue 3, 2010, Pages 613-622

  Vismara, Elena ^a   Pierini, Monica ^a   Mascellani, Giuseppe ^b   Liverani, Lino ^b   Lima, Marcelo ^c   Guerrini, Marco ^d   Torri, Giangiacomo ^d  

^a POLITECNICO DI MILANO   (Italy)

^b Opocrin SpA   (Italy)

^c Universidade Federal   (Brazil)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Fenton type reaction; Heparin radical; LMWH; NMR; Transition metal ions

Indexed keywords

COPPER ION; FERROUS ION; FERROUS SULFATE; GLUCOSAMINE DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CATALYSIS; DEPOLYMERIZATION; PRIORITY JOURNAL;

ANIMALS; COPPER; FACTOR XA; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYDROGEN PEROXIDE; IRON; PROTHROMBIN; SWINE;

EID: 77749254954     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-02-0084     Document Type: Article

References (20)

1. Casu B. Structure and active domains of heparin. In: Chemistry and Biology of Heparin and Heparan Sulfate. Oxford, Elsevier; 2005: pp. 1-28.
2. Casu B, Torri G. Structural characterization of low molecular weight heparins. Semin Thromb Hemost 1999; 25: 17-25.
3. Linhardt JR, Gunay NS, Production and chemical processing of low molecular weight heparins. Semin Thromb Hemost 1999; 25: 5-16.
4. Bisio A, Guglieri S, Frigerio M, et al. Controlled g-ray irradiation of heparin generates oligosaccharides enriched in highly sulfated sequences. Carbohydr Polym 2004; 55: 101-112.
5. Vismara E, Pierini M, Guglieri S, et al. Structural modification induced in heparin by a Fenton-type depolymerization process. Semin Thromb Hemost 2007; 33: 466-477.
6. Fareed J, Ma Q, Florian M, et al. Differentiation of low molecular-weight heparins: impact on the future of the management of thrombosis. Semin Thromb Hemost 2004; 30 (Suppl 1): 89-104.
7. Edwards JO, Curci R. Fenton type activation and chemistry of hydroxyl radical. In: Catalytic oxidations with hydrogen peroxide as oxidant (Strukul G, ed). London, Kluwer Academic Publishers; 1992: pp. 97-153.
8. De La Mare HE, Kochi JK, Rust FF. The oxidation and reduction of free radicals by Me salts. J Am Chem Soc 1963; 85: 1437-1449.
9. Payne GB, Deming PH, Williams PH. Reaction of hydrogen peroxide. Alkali-catalyzed epoxidation and oxidation using a nitrile as co-reactant. J Org Chem 1961; 26: 659-663.
10. Mascellani G, Liverani L, Bianchini P, et al. Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequence of dermatan sulphate. Biochem J 1993; 296: 639-648.
11. Yates EA, Santini F, De Cristofano B, et al. Effect of substitution pattern on 1H, 13C NMR chemical shifts and 1JCH coupling constants in heparin derivatives. Carbohydr Res 2000; 329: 239-247.
12. Guerrini M, Naggi A, Guglieri S, et al. Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy. Anal Biochem 2005; 337: 35-47.
13. Rota C, Liverani L, Spelta F, et al. Free radical generation during chemical depolymerisation of heparin. Anal Biochem 2005; 344: 193-203.
14. Torri G, Guerrini M. Quantitative 2D NMR analysis of glycosaminoglycans. In: NMR Spectroscopy in Pharmaceutical Analysis. Integra, India, Elsevier; 2008; Part III Chapter 04 12-5; 407.
15. Lindahl U, Thunberg L, Bäckström G, et al. The antithrombin-binding sequence of heparin. Biochem Soc Trans 1981; 9: 499-551.
16. Casu B, Oreste P, Torri G, et al. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C-NMR studies. Biochem J 1981; 197: 599-609.
17. Guerrini M, Guglieri S, Casu B, et al. Antithrombin binding octasaccharides: role of extensions of the active pentasaccharide sequence on the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue. J Biol Chem 2008; 39: 26662-26675.
18. Abraham RJ, Loftus P. Proton and Carbon-13 NMR Spectroscopy. An integrated approach. London, Heyden & Son Ltd; 1978.
19. Fransson L, Malmström A, Sjöberg I, et al. Periodate oxidation and alkaline degradation of heparin -related glycans. Carbohydr Res 1980; 80: 131-145.
20. Walenga JM, Jeske WP, Fareed J. Biochemical and Pharmacological Rationale for Synthetic Heparin Pentasaccharides. In Chemistry and Biology of Heparin and Heparan Sulfate. Oxford, Elsevier; 2005: pp. 143-178.